Advanced Search:
Equity Index

ONWD.BR - ONWARD MEDICAL

€4.92  0.01 (0.2%)

Updated: 08:21 May 8, 2024 EST

Next Session's AI Forecast

97.38%

Avg. Accuracy (AI)

€4.84

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

€4.76

ONWARD MEDICAL's Position Within the Biotechnology Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

ONWARD MEDICAL - HISTORICAL DATA 6M

  • Last price

    €4.92

  • Daily change

    €0.01

  • Previous Close

    €4.91

  • Last Updated

    08:21 May 8, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.69 -1.14 -0.16 0.34 0.07

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
2.7 2.96 5.12 4.97 3.77

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
85% 86.36% 18.18% 22.02%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
4.83 0.21% 4.82 -4.55% 5.05 23.17% 4.1

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.36 42.86 0.57 26.47

ONWARD MEDICAL Technical Analysis News

ONWARD MEDICAL

High Tech Campus 32
Eindhoven NL-5656
Netherlands

https://www.onwd.com

Sectors: Healthcare
Industry: Biotechnology
F. Time Employees: 96
Description

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Corporate Governance

Onward Medical N.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

ONWARD MEDICAL'S HOLDERS RANK

List of holders with stock participation in ONWARD MEDICAL.

Holder Rank Holder Shares Date Reported % Out Value